What is the price-to-earnings ratio of Biomerica?
The price-earnings ratio of Biomerica is currently 1.82.
Biomerica P/S 2024
Biomerica P/S
1.82
Ticker
BMRA
ISIN
US09061H3075
WKN
866251
As of Nov 23, 2024, Biomerica's P/S ratio stood at 1.82, a -46.31% change from the 3.39 P/S ratio recorded in the previous year.
The Biomerica P/S history
Biomerica Aktienanalyse
What does Biomerica do?
Biomerica Inc. is an American company specializing in the development and marketing of medical diagnostic products. The company was founded in 1971 by Dr. Zackary Irani and is headquartered in Irvine, California. Biomerica Inc. develops and sells a wide range of medical diagnostic products, including in vitro diagnostic products (IVD). They are also involved in the development and distribution of real-time testing systems for food and environmental monitoring. Additionally, Biomerica Inc. offers diagnostic tests for autoimmune diseases such as celiac disease, lupus, and rheumatoid arthritis. Overall, the company aims to contribute to the fast and effective treatment of patients by providing easy-to-use diagnostic products and services. Biomerica ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Biomerica's P/S Ratio
Biomerica's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Biomerica's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Biomerica's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Biomerica’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Biomerica stock
How has the price-earnings ratio of Biomerica changed compared to last year?
The price-to-earnings ratio of Biomerica has increased by -46.31% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Biomerica high compared to other companies?
Yes, the price-to-earnings ratio of Biomerica is high compared to other companies.
How does an increase in the price-earnings ratio of Biomerica affect the company?
An increase in the price-earnings ratio of Biomerica would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Biomerica affect the company?
A decrease in the price-earnings ratio of Biomerica would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Biomerica?
Some factors that influence the price-earnings ratio of Biomerica are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Biomerica pay?
Over the past 12 months, Biomerica paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biomerica is expected to pay a dividend of 0 USD.
What is the dividend yield of Biomerica?
The current dividend yield of Biomerica is .
When does Biomerica pay dividends?
Biomerica pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Biomerica?
Biomerica paid dividends every year for the past 0 years.
What is the dividend of Biomerica?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Biomerica located?
Biomerica is assigned to the 'Health' sector.
Wann musste ich die Aktien von Biomerica kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Biomerica from 11/23/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/23/2024.
When did Biomerica pay the last dividend?
The last dividend was paid out on 11/23/2024.
What was the dividend of Biomerica in the year 2023?
In the year 2023, Biomerica distributed 0 USD as dividends.
In which currency does Biomerica pay out the dividend?
The dividends of Biomerica are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Biomerica
Our stock analysis for Biomerica Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biomerica Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
